All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy

Newly Recruited CD11b+, GR-1+, Ly6ChighMyeloid Cells Augment Tumor-Associated Immunosuppression Immediately following the Therapeutic Administration of Oncolytic Reovirus

(2015) Derek R. Clements et al.   JOURNAL OF IMMUNOLOGY

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity

(2015) Carolina S Ilkow et al.   NATURE MEDICINE

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

(2013) S A Gujar et al.   BRITISH JOURNAL OF CANCER

Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?

(2013) Celeste Goh et al.   IMMUNOLOGICAL REVIEWS

Bacteriology: A caring culture

(2013) Sarah DeWeerdt   NATURE

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

NK Cell Response to Vaccinia Virus Is Regulated by Myeloid-Derived Suppressor Cells

(2012) C. Fortin et al.   JOURNAL OF IMMUNOLOGY